摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2,6,6-tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide | 1362021-40-6

中文名称
——
中文别名
——
英文名称
2,2,6,6-tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide
英文别名
——
2,2,6,6-tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide化学式
CAS
1362021-40-6
化学式
C24H26ClFN5O2
mdl
——
分子量
470.954
InChiKey
IOVAIZPMGLENIU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    33
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    71.2
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    4-羧基-2,2,6,6-四甲基氮杂环己烷-1-氧基自由基N4-(3-氯-4-氟苯基)-4,6-喹唑啉二胺1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 0.5h, 以18%的产率得到2,2,6,6-tetramethyl-1-oxyl-N-[4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl]piperidine-4-carboxamide
    参考文献:
    名称:
    Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents
    摘要:
    4-anilinoquinazoline and 4-anilinoquinoline scaffolds bearing a 2,2,6,6-tetramethylpiperidine-N-oxy-1(TEMPO) have been synthesized and evaluated for their ability to inhibit EGFR tyrosine kinase and A431 cell lines. Compared to their corresponding parent compounds, all of the new compounds bearing a TEMPO showed more efficient inhibition for EGFR and A431 cells. Furthermore, we have proved that these molecules bearing a TEMPO can exactly get into A431 cells exerting inhibitory effect that may be used for EPR detecting. In our docking model, quinazolines bearing a TEMPO on either 6- or 3-positions took different linking modes according to EGFR crystal structure. In contrast to their parent compounds, these new TEMPO-derived analogues possessed compatible inhibitory effect that might be useful as potential EGFR inhibitors and as EPR bio-probes. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.01.021
点击查看最新优质反应信息

文献信息

  • Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents
    作者:Siyuan Li、Chunying Guo、Xianqiang Sun、Yaozong Li、Hongli Zhao、Dongmei Zhan、Minbo Lan、Yun Tang
    DOI:10.1016/j.ejmech.2012.01.021
    日期:2012.3
    4-anilinoquinazoline and 4-anilinoquinoline scaffolds bearing a 2,2,6,6-tetramethylpiperidine-N-oxy-1(TEMPO) have been synthesized and evaluated for their ability to inhibit EGFR tyrosine kinase and A431 cell lines. Compared to their corresponding parent compounds, all of the new compounds bearing a TEMPO showed more efficient inhibition for EGFR and A431 cells. Furthermore, we have proved that these molecules bearing a TEMPO can exactly get into A431 cells exerting inhibitory effect that may be used for EPR detecting. In our docking model, quinazolines bearing a TEMPO on either 6- or 3-positions took different linking modes according to EGFR crystal structure. In contrast to their parent compounds, these new TEMPO-derived analogues possessed compatible inhibitory effect that might be useful as potential EGFR inhibitors and as EPR bio-probes. (C) 2012 Elsevier Masson SAS. All rights reserved.
查看更多